Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease headache
Phenotype C0042373|vascular diseases
Sentences 1
PubMedID- 23890176 Yxqn (tianjin tasly pharmaceutical co. ltd., tianjin, china) is a newly developed compound medicine that was approved in 1996 by the china state food and drug administration for the treatment of headache and dizziness associated with cerebrovascular diseases.

Page: 1